A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
18-methyl-19-nortestosterone
Cimicoxib
Potassium gluconate may increase the hyperkalemic activities of Cimicoxib.
18-methyl-19-nortestosterone
Clevidipine
Potassium gluconate may increase the hyperkalemic activities of Clevidipine.
18-methyl-19-nortestosterone
Nebivolol
Potassium gluconate may increase the hyperkalemic activities of Nebivolol.
18-methyl-19-nortestosterone
Celiprolol
Potassium gluconate may increase the hyperkalemic activities of Celiprolol.
18-methyl-19-nortestosterone
Fluspirilene
Potassium gluconate may increase the hyperkalemic activities of Fluspirilene.
18-methyl-19-nortestosterone
Flunarizine
Potassium gluconate may increase the hyperkalemic activities of Flunarizine.
18-methyl-19-nortestosterone
Cyclandelate
Potassium gluconate may increase the hyperkalemic activities of Cyclandelate.
18-methyl-19-nortestosterone
Zomepirac
Potassium gluconate may increase the hyperkalemic activities of Zomepirac.
18-methyl-19-nortestosterone
Prenylamine
Potassium gluconate may increase the hyperkalemic activities of Prenylamine.
18-methyl-19-nortestosterone
Metamizole
Potassium gluconate may increase the hyperkalemic activities of Metamizole.
18-methyl-19-nortestosterone
Benoxaprofen
Potassium gluconate may increase the hyperkalemic activities of Benoxaprofen.
18-methyl-19-nortestosterone
Nimesulide
Potassium gluconate may increase the hyperkalemic activities of Nimesulide.
18-methyl-19-nortestosterone
Penicillin G Acyl-Serine
Potassium gluconate may increase the hyperkalemic activities of Penicillin G Acyl-Serine.
18-methyl-19-nortestosterone
Etoricoxib
Potassium gluconate may increase the hyperkalemic activities of Etoricoxib.
18-methyl-19-nortestosterone
Tiaprofenic acid
Potassium gluconate may increase the hyperkalemic activities of Tiaprofenic acid.
18-methyl-19-nortestosterone
Candesartan
Potassium gluconate may increase the hyperkalemic activities of Candesartan.
18-methyl-19-nortestosterone
Azilsartan medoxomil
Potassium gluconate may increase the hyperkalemic activities of Azilsartan medoxomil.
18-methyl-19-nortestosterone
Saralasin
Potassium gluconate may increase the hyperkalemic activities of Saralasin.
18-methyl-19-nortestosterone
Canrenone
The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Canrenone.
18-methyl-19-nortestosterone
Canrenoic acid
The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Canrenoic acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3